According to the 2024 AHA/ACC guidelines, how many days before elective spine surgery should low‑dose aspirin be discontinued, and what are the recommendations for patients on aspirin for secondary prevention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

2024 AHA/ACC Aspirin Management for Spine Surgery

According to the 2024 AHA/ACC guidelines, aspirin should generally be continued perioperatively for patients with coronary artery disease (CAD) undergoing noncardiac surgery, including spine procedures, unless the bleeding risk is prohibitive. 1

Primary Recommendation from 2024 Guidelines

The 2024 AHA/ACC perioperative guidelines provide a nuanced, risk-stratified approach rather than a blanket discontinuation period:

For Patients WITH Prior PCI (Stents):

  • Continue aspirin (75-100 mg) perioperatively if possible to reduce cardiac events (Class 1, Level B-R) 1
  • This applies even when other antiplatelet agents must be stopped
  • The guideline explicitly states aspirin continuation is recommended to minimize major adverse cardiac events (MACE)

For Patients WITHOUT Prior PCI:

  • May continue aspirin when cardiac risk outweighs bleeding risk (Class 2b, Level B-R) 1
  • Routine initiation of aspirin is NOT beneficial for primary prevention (Class 3, Level B-R) 1

Critical Decision Framework

The 2024 guidelines emphasize that management should be determined by a multidisciplinary team weighing bleeding risk, thrombosis risk, and consequences of delayed surgery (Class 1, Level B-NR) 1. This is particularly relevant for spine surgery, which carries high bleeding risk.

When Aspirin Discontinuation IS Considered:

If aspirin must be stopped for high-bleeding-risk spine surgery:

The 2022 CHEST guidelines (which complement the AHA/ACC recommendations) suggest:

  • Stop aspirin ≤7 days before surgery (not 7-10 days) for elective procedures requiring interruption 2
  • This represents a shorter discontinuation window than older recommendations

The 2024 AHA/ACC guidelines do not specify exact discontinuation timing, instead prioritizing continuation whenever feasible 1.

Special Populations Requiring Aspirin Continuation

Aspirin should be continued through surgery in these high-risk scenarios:

  1. Recent stent placement:

    • Within 30 days of bare-metal stent (BMS) or drug-eluting stent (DES): Continue dual antiplatelet therapy unless bleeding risk is extreme 1
    • 30 days to 3 months post-DES: Continue aspirin at minimum 1
    • Beyond 3 months: Continue aspirin perioperatively 1
  2. Secondary prevention patients:

    • History of MI, stroke, or established CAD
    • The 2012 AHA/ACC transplant statement noted aspirin should be continued if possible and restarted quickly if stopped 3

Practical Algorithm for Spine Surgery

Step 1: Identify indication for aspirin

  • Primary prevention (no CAD/stroke) → May stop if needed
  • Secondary prevention (prior MI/stroke/stent) → Strong preference to continue

Step 2: Assess bleeding risk of specific spine procedure

  • Intracranial/spinal cord surgery = highest risk
  • Multi-level fusion = high risk
  • Single-level decompression = moderate risk

Step 3: Timing decision

  • If continuing aspirin: Use 75-100 mg daily dose 1
  • If stopping aspirin:
    • Stop ≤7 days preoperatively (not the older 7-10 day recommendation) 2
    • Restart within 24 hours postoperatively when hemostasis adequate 2

Step 4: Coordinate with cardiology

  • Mandatory for patients with stents placed within 12 months 1
  • Recommended for all secondary prevention patients

Important Caveats

The 2024 guidelines represent a paradigm shift from older recommendations that routinely stopped aspirin 7-10 days preoperatively. The current evidence-based approach prioritizes:

  1. Continuation over discontinuation when possible 1
  2. Shorter discontinuation periods (≤7 days, not 7-10 days) when necessary 2
  3. Individualized risk assessment rather than blanket protocols 1

Common pitfall: Older literature and some surgical practices still recommend 7-10 day discontinuation 4, 5. However, the most recent high-quality guidelines (2024 AHA/ACC and 2022 CHEST) support shorter interruption periods or continuation 1, 2.

For spine surgery specifically: While research suggests increased bleeding with aspirin continuation 4, 6, the 2024 guidelines prioritize cardiac risk reduction. A 2023 Delphi consensus of spine surgeons recommended stopping aspirin 7 days preoperatively 7, which aligns with the ≤7 day recommendation from CHEST guidelines 2 but conflicts with the AHA/ACC preference for continuation 1.

Postoperative Management

  • Resume aspirin within 24 hours after surgery when hemostasis is adequate 2
  • Earlier resumption (within 24 hours) preferred over delayed resumption 2
  • For secondary prevention patients, total cessation duration should be <7-10 days to minimize thrombotic risk 6

The key principle: In 2024, the default is aspirin continuation unless bleeding risk clearly outweighs cardiac risk, with discontinuation periods shortened to ≤7 days when necessary.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.